A six‐month randomized, controlled, double‐blind, dose‐response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis - Concepedia

Concepedia

Publication | Closed Access

A six‐month randomized, controlled, double‐blind, dose‐response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug–refractory ankylosing spondylitis

234

Citations

41

References

2002

Year

Walter P. Maksymowych, Gian S. Jhangri, Avril A. Fitzgerald, Sharon LeClercq, Alex Yan, Kenneth J. Skeith, Stephen Aaron, Joanne Homik, Paul J. Davis, Dale Sholter,

Arthritis & Rheumatism

Abstract

Pamidronate has dose-dependent therapeutic properties in AS.

References

	Year	Citations

Page 1